|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS11339 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-phospho-SCNN1B(Ser633) |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human Syncytin 1 |
合胞素1抗體品牌 英文名稱 Anti-Syncytin 1/HERV
中文名稱 合胞素1抗體品牌
別 名 Endogenous retrovirus group W member 1; env; Env-W; Envelope polyprotein gPr73; Enverin; ENW1_HUMAN; ERVW; ERVW-1; Gp24; Gp50; HERV-7q Envelope protein; HERV-W envelope protein; HERVW; SU; Syncytin 1; Syncytin; Syncytin-1; TM; Transmembrane protein.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 微生物學(xué) 細(xì)菌及
蛋白分子量 predicted molecular weight: 33/58kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Syncytin 1
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
合胞素1抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has retained its original fusogenic properties and participates in trophoblast fusion during placenta morphogenesis.
SU mediates receptor recognition. This interaction triggers the refolding of the transmembrane protein (TM) and is thought to activate its fusogenic potential by unmasking its fusion peptide (By similarity). Seems to recognize the type D mammalian retrovirus receptors SLC1A4 and SLC1A5, as it induces fusion of cells expressing these receptors in vitro.
The transmembrane protein (TM) acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of membranes.
Function : Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has retained its original fusogenic properties and participates in trophoblast fusion during placenta morphogenesis.
SU mediates receptor recognition. This interaction triggers the refolding of the transmembrane protein (TM) and is thought to activate its fusogenic potential by unmasking its fusion peptide (By similarity). Seems to recognize the type D mammalian retrovirus receptors SLC1A4 and SLC1A5, as it induces fusion of cells expressing these receptors in vitro.
The transmembrane protein (TM) acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of membranes (By similarity).
Subunit : The mature envelope protein (Env) consists of a trimer of SU-TM heterodimers attached probably by a labile interchain disulfide bond. Interacts with the C-type lectin CD209/DC-SIGN.
Subcellular Location : Transmembrane protein: Cell membrane; Single-pass type I membrane protein (By similarity).
Surface protein: Cell membrane; Peripheral membrane protein (By similarity). Note=The surface protein is not anchored to the membrane, but localizes to the extracellular surface through its binding to TM (By similarity).
HERV-W_7q21.2 provirus ancestral Env polyprotein: Virion (By similarity).
Tissue Specificity : Expressed at higher level in placental syncytiotrophoblast. Expressed at intermediate level in testis. Seems also to be found at low level in adrenal tissue, bone marrow, breast, colon, kidney, ovary, prostate, skin, spleen, thymus, thyroid, brain and trachea. Both mRNA and protein levels are significantly increased in the brain of individuals with multiple sclerosis, particularly in astrocytes and microglia.
Post-translational modifications : Specific enzymatic cleavages in vivo yield mature proteins. Envelope glycoproteins are synthesized as a inactive precursor that is heavily N-glycosylated and processed likely by furin in the Golgi to yield the mature SU and TM proteins. The cleavage site between SU and TM requires the minimal sequence [KR]-X-[KR]-R. The intracytoplasmic tail cleavage by the viral protease that is required for the fusiogenic activity of some retroviruses envelope proteins seems to have been lost during evolution.
The CXXC motif is highly conserved across a broad range of retroviral envelope proteins. It is thought to participate in the formation of a labile disulfide bond possibly with the CX6CC motif present in the transmembrane protein. Isomerization of the intersubunit disulfide bond to an SU intrachain disulfide bond is thought to occur upon receptor recognition in order to allow membrane fusion (By similarity).
Similarity : Belongs to the gamma type-C retroviral envelope protein family. HERV class-I W env subfamily.
Database links : UniProtKB/Swiss-Prot: Q9UQF0.1
合胞素(Syncytin)是一類由人俘獲的逆轉(zhuǎn)錄囊膜蛋白,與胎盤的形態(tài)發(fā)生中細(xì)胞滋養(yǎng)層到合胞滋養(yǎng)層的分化過程相關(guān)。Syncytin與人I型(-1)囊膜蛋白(Env)在結(jié)構(gòu)上具有相似的特點,二者可能具有相似的膜融合機制。
實驗流程：
全、新、優(yōu)、品、好四大特點：
合胞素1抗體品牌 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品：
Anti-A/H1N1-M2 Human /Biotin 生物素標(biāo)記兔抗人A型人病毒H1N1-M2抗體IgGMulti-class antibodies規(guī)格： 0.2ml
PACAP-27/38 腺苷酸環(huán)化酶激活肽-27/38(抗原)Multi-class antibodies規(guī)格： 0.5mg
CD90抗體 Anti-Thy-1/CD90 0.1ml
SPDYA 英文名稱： 細(xì)胞周期G2/M期快速誘導(dǎo)蛋白SPDYA抗體 0.2ml
ECE2 英文名稱： 內(nèi)皮素轉(zhuǎn)化酶2抗體 0.1ml
Rhesus antibody Rh phospho-Kv2.1(Tyr128) 磷酸化通道蛋白DRK1抗體 規(guī)格 0.1ml
PACAP-27/38 腺苷酸環(huán)化酶激活肽-27/38(抗原)Multi-class antibodies規(guī)格： 0.5mg
Anti-phospho-P53 (Ser315)/FITC 熒光素標(biāo)記磷酸化抑制基因P53抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rabbit Anti-goat IgM/Biotin 生物素化兔抗羊IgMMulti-class antibodies規(guī)格： 0.3ml
兔抗小胸腺DNA 抗體 Anti-CT DNA 0.2ml
Rabbit Anti-mouse IgM/PE-Cy3 PE-Cy3標(biāo)記的兔抗小鼠IgM 0.1ml
FCGBP 英文名稱： Fcγ免疫球蛋白IgG結(jié)合蛋白抗體 0.2ml
Rhesus antibody Rh phospho-YES1(Tyr426) 磷酸化原癌基因酪氨酸蛋白激酶Yes1抗體 規(guī)格 0.1ml
Rabbit Anti-goat IgM/Biotin 生物素化兔抗羊IgMMulti-class antibodies規(guī)格： 0.3ml
LFABP/FABP-1(Liver Fatty acid binding protein) *型脂肪酸結(jié)合蛋白抗原Multi-class antibodies規(guī)格： 0.5mg
Anti-Adenylate Kinase 1/ AK1 腺苷酸激酶-1抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh phospho-c-Abl(Tyr276) 磷酸化非受體酪氨酸激酶c-Abl抗體 規(guī)格 0.1ml
AP-Streptavidin專用稀釋液 10ml pH 7.6,高背景或AP存在時推薦使用
VAX2 英文名稱： 視神經(jīng)視網(wǎng)膜相關(guān)蛋白VAX2抗體 0.2ml
phospho-DAXX (Ser671) 英文名稱： 磷酸化Fas相關(guān)死亡結(jié)構(gòu)域蛋白抗體 0.1ml
Anti-Adenylate Kinase 1/ AK1 腺苷酸激酶-1抗體Multi-class antibodies規(guī)格： 0.2ml
IFNG Protein Human 重組人 IFN-gamma / IFNG / γ-IFN 蛋白
大鼠神經(jīng)小膠質(zhì)細(xì)胞完全培養(yǎng)基 100mL
CD63 Others Sus scrofa (Pig) 野豬 CD63 / Tspan-30 / Teaspanin-30 人細(xì)胞裂解液 (陽性對照)
NUGC-3人細(xì)胞 Human gasic cancer cells NUGC-3 1640+10% FBS
NRK-52E，大鼠腎細(xì)胞
NCI-H2087(人非小細(xì)胞) 5×106cells/瓶×2 Mo-MuLv/3T3(Mo-MuLv感染的3T3細(xì)胞)
CM-R087大鼠軟骨細(xì)胞完全培養(yǎng)基100mL
HA Others H7N9 甲型 H7N9 (A/Pigeon/Shanghai/S1069/2013) 血凝素 (Hemagglutinin / HA) 桿狀病毒-昆蟲細(xì)胞裂解液 (陽性對照)
小鼠海馬趾星形膠質(zhì)細(xì)胞MA-h
猴腎細(xì)胞;Vero IgCD4 人巨核細(xì)胞，CHRF細(xì)胞 SK-N-MC(神經(jīng)上皮瘤細(xì)胞)
EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞;KMY0928
GFRA2 Others Mouse 小鼠 GFRA2 / GFRα2 / GDNFRB 人細(xì)胞裂解液 (陽性對照)
合胞素1抗體品牌 IFNG Protein Human 重組人 IFN-gamma / IFNG / γ-IFN 蛋白
大鼠神經(jīng)小膠質(zhì)細(xì)胞完全培養(yǎng)基 100mL
CD63 Others Sus scrofa (Pig) 野豬 CD63 / Tspan-30 / Teaspanin-30 人細(xì)胞裂解液 (陽性對照)
NUGC-3人細(xì)胞 Human gasic cancer cells NUGC-3 1640+10% FBS
NRK-52E，大鼠腎細(xì)胞
NCI-H2087(人非小細(xì)胞) 5×106cells/瓶×2 Mo-MuLv/3T3(Mo-MuLv感染的3T3細(xì)胞)
技術(shù)外包服務(wù):
★合胞素1抗體品牌 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程：原核、哺乳動物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
|
|
|
|
